Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the business’s stock in a transaction on Monday, November 16th. The shares were sold at an average price of $444.38, for a total value of $20,441.48. Following the completion of the sale, the executive vice president owned 411 shares of the company’s stock, valued at $182,640.18. This trade represents a 10.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Friday, November 20th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $407.24, for a total transaction of $18,733.04.
- On Wednesday, November 18th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $430.63, for a total transaction of $19,808.98.
- On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total value of $26,937.60.
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The shares were sold at an average price of $451.75, for a total transaction of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total transaction of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $350.20, for a total value of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $361.23, for a total value of $16,616.58.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89.
Intuitive Surgical Stock Performance
Shares of ISRG opened at $399.06 on Friday. The stock has a market capitalization of $138.33 billion, a price-to-earnings ratio of 48.25, a PEG ratio of 3.02 and a beta of 1.45. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a fifty day moving average of $423.51 and a 200-day moving average of $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same period in the previous year, the business posted $2.40 earnings per share. The business’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Institutional Trading of Intuitive Surgical
A number of hedge funds and other institutional investors have recently bought and sold shares of ISRG. Bank of America Corp DE increased its position in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares during the last quarter. Bank of New York Mellon Corp bought a new position in shares of Intuitive Surgical during the 2nd quarter valued at $1,335,753,000. Amundi increased its holdings in shares of Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock worth $1,119,448,000 after buying an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Intuitive Surgical by 10.8% in the third quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after buying an additional 184,044 shares during the period. Institutional investors own 83.64% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently issued reports on ISRG shares. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 22nd. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a report on Tuesday. BTIG Research boosted their target price on Intuitive Surgical from $454.00 to $513.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Mizuho reduced their price target on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $495.90.
Get Our Latest Stock Analysis on Intuitive Surgical
Key Intuitive Surgical News
Here’s some of the latest news about ISRG:
- Positive Sentiment: Industry coverage casts Intuitive Surgical as a leading beneficiary of expanding surgical-robotics adoption, citing growth in robotic procedures and use of its da Vinci system. A separate medical-device roundup also identifies ISRG as a stock to watch, though neither story reports a new company announcement. Surgical robotics industry article Medical-device stocks article
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
